Research Output per year
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 6 Similar Profiles
B-Cell Chronic Lymphocytic Leukemia
Medicine & Life Sciences
Cytarabine
Medicine & Life Sciences
gemcitabine
Medicine & Life Sciences
Arabinofuranosylcytosine Triphosphate
Medicine & Life Sciences
Leukemia
Medicine & Life Sciences
Acute Myeloid Leukemia
Medicine & Life Sciences
Nucleosides
Medicine & Life Sciences
Apoptosis
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1982 2019
Extracellular Flux Assays to Determine Oxidative Phosphorylation and Glycolysis in Chronic Lymphocytic Leukemia Cells
Vangapandu, H. V. & Gandhi, V. V., Jan 1 2019, Methods in Molecular Biology. Humana Press Inc., p. 121-128 8 p. (Methods in Molecular Biology; vol. 1881).Research output: Chapter in Book/Report/Conference proceeding › Chapter
Oxidative Phosphorylation
Glycolysis
B-Cell Chronic Lymphocytic Leukemia
Suspensions
Smegmamorpha
Ex Vivo Pharmacological Profiling in Chronic Lymphocytic Leukemia Cells
Aslan, B., Ayres, M. L. & Gandhi, V. V., Jan 1 2019, Methods in Molecular Biology. Humana Press Inc., p. 19-25 7 p. (Methods in Molecular Biology; vol. 1881).Research output: Chapter in Book/Report/Conference proceeding › Chapter
B-Cell Chronic Lymphocytic Leukemia
Pharmacology
Pharmaceutical Preparations
Drug Combinations
Lymphocytes
In Vitro Assay to Study CLL and Monocyte Interactions
Bertilaccio, M. T. S., Zhang, R., Banerjee, P. & Gandhi, V. V., Jan 1 2019, Methods in Molecular Biology. Humana Press Inc., p. 113-119 7 p. (Methods in Molecular Biology; vol. 1881).Research output: Chapter in Book/Report/Conference proceeding › Chapter
Monocytes
Flow Cytometry
Drug Delivery Systems
Drug Interactions
Color
3
Citations
A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia
Short, N. J., Kantarjian, H. M., Ravandi-Kashani, F., Huang, X., Xiao, L., Garcia-Manero, G., Plunkett Jr, W. K., Gandhi, V. V., Sasaki, K., Pemmaraju, N., Daver, N., Borthakur, G., Jain, N., Konopleva, M., Estrov, Z., Kadia, T. M., Wierda, W. G., DiNardo, C., Brandt, M., O’Brien, S. M. & 2 others, Jul 19 2018, In : Leukemia and Lymphoma. 59, 4, p. 813-820 8 p.Research output: Contribution to journal › Article
Idarubicin
Cytarabine
Acute Myeloid Leukemia
Purine Nucleosides
Random Allocation
A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia
Dalle, I. A., Cortes, J. E., Pinnamaneni, P., Lamothe, B., Duque, A. D., Randhawa, J., Pemmaraju, N., Jabbour, E. J., Ferrajoli, A., Wierda, W. G., Estrov, Z., Konopleva, M., Ravandi-Kashani, F., Alvarado, Y., Borthakur, G., Gandhi, V. V. & Kantarjian, H. M., Sep 1 2018, In : Acta haematologica. 140, 1, p. 30-39 10 p.Research output: Contribution to journal › Article
Acute Myeloid Leukemia
Therapeutics
Disease Progression
Erlotinib Hydrochloride
Exanthema